A new startup called Trestle Biotherapeutics is working on creating kidney tissues that could transform kidney replacement therapies.
The team will combine 3D bioprinting and stem cell-based tissue engineering to build functioning kidney tissues. Both kidney technologies have been developed over several years by various groups of scientists from different universities and hospitals.
The bioengineered kidney tissues will have the ability to function as healthy kidney tissues would. This will provide new ways to treat incurable kidney diseases and hopefully become the new treatment option for patients with kidney failure.
Do you think this technology will finally answer kidney transplant needs worldwide? Will it eventually decrease the number of patients needing replacement therapies such as dialysis? Please comment your thoughts below.